Literature DB >> 1615598

Renal cell carcinoma: incidental diagnosis and natural history: review of 235 cases.

R A Mevorach1, A J Segal, M E Tersegno, I N Frank.   

Abstract

Two hundred thirty-five cases of histologically proved renal cell carcinoma (1976-1987) were reviewed to determine the impact of incidental tumor detection on the natural history of this cancer. One hundred sixty-eight patients (71.5%) presented with clinical signs and/or symptoms of renal pathology. Of these, 25 (18%) were investigated without consideration of renal cell carcinoma in the differential diagnosis. Sixty-seven cases (28.5%) were diagnosed as an incidental finding on diagnostic imaging for extrarenal symptomatology. Approximately 30 percent of patients were found to have metastatic disease on initial presentation regardless of incidental, or suspected discovery of these tumors. Stages A and B tumors were encountered with equal frequency in patient groups with both suspected and incidental diagnosis. Intravenous pyelography was the diagnostic modality used to detect the diagnosis in 83 percent of cases. While incidental detection of renal cell carcinoma has become more frequent than in previous years, it appears to have impacted minimally on the discovery of earlier stage tumors than those with presenting clinical symptoms. In contrast to prior reports, our data show that the natural history of renal cell carcinoma is not significantly altered by the incidental detection of tumor.

Entities:  

Mesh:

Year:  1992        PMID: 1615598     DOI: 10.1016/0090-4295(92)90006-i

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma.

Authors:  Peter E Clark
Journal:  Biologics       Date:  2010-08-09

2.  Is there a need for pelvic CT scan in cases of renal cell carcinoma?

Authors:  Anurag Khaitan; Narmada P Gupta; Ashok K Hemal; P N Dogra; Amlesh Seth; Monish Aron
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

3.  Current status of targeted therapy for advanced renal cell carcinoma.

Authors:  In-Chang Cho; Jinsoo Chung
Journal:  Korean J Urol       Date:  2012-04-18

4.  Incidental vs symptomatic renal tumours: Survival outcomes.

Authors:  Mohammed S Al-Marhoon; Ahmed Mosbah Osman; Mohammed M Kamal; Ahmed A Shokeir
Journal:  Arab J Urol       Date:  2011-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.